Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Coridon Pty. Ltd.
DescriptionHSV-2 glycoprotein D (gD2)-based DNA vaccine
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: DNA vaccine
Latest Stage of DevelopmentPreclinical
Standard IndicationHerpes simplex virus (HSV)
Indication DetailsTreat herpes simplex virus (HSV) type 2 infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today